Compounded Semaglutide vs Wegovy: What's the Difference?
Quick Answer: Compounded semaglutide or Wegovy — what's the real difference?
Wegovy is Novo Nordisk's FDA-approved semaglutide product. Compounded semaglutide is prepared by a licensed US compounding pharmacy for one patient, pursuant to a licensed provider's prescription; it is not FDA-approved and is not a generic or substitute for Wegovy. The differences that matter are regulatory oversight, how each is made and dispensed, and dose form. Which one is appropriate for you is a clinical decision made by a licensed provider based on your health history — not a cost decision.
FDA Approval Status
Wegovy is Novo Nordisk's brand-name semaglutide, FDA-approved for chronic weight management. Approval means the product's manufacturing process, dosing, labeling, and clinical evidence — including the STEP trials — were reviewed by the FDA, and the manufacturer remains subject to FDA inspection and post-market reporting requirements.
Compounded semaglutide is not FDA-approved. The final compounded product does not go through FDA review for safety, effectiveness, or manufacturing quality, and its formulation may differ from the commercial product. It is not a generic version of Wegovy and is not a substitute for it. This is the single most important difference, and any program offering compounded medication should say it clearly.
What Compounding Actually Is
Compounding is the practice of a licensed pharmacist preparing a medication for an individual patient based on a licensed prescriber's order. It exists to serve patients whose needs are not met by a commercially available product — for example, a different dose, a different form, or the removal of an ingredient a patient cannot tolerate.
In 2025 the FDA declared the semaglutide shortage resolved, ending the period in which pharmacies could compound copies of the commercial product at scale. Hims wound down compounded semaglutide for new patients and Ro moved to brand-name only. Compounding continues where it always was permitted: patient-specific prescriptions written by a licensed provider and filled by a licensed pharmacy. That is the model smaller platforms, including FitFlowRx, operate under today.
Who Prescribes and Who Dispenses
Both routes require a prescription from a licensed provider after a review of your health history. Wegovy can be prescribed by any licensed prescriber and filled at a retail pharmacy, through insurance, or through Novo Nordisk's self-pay program. Compounded semaglutide is prescribed by a licensed provider who determines that a patient-specific preparation is appropriate, and it is dispensed by a licensed US compounding pharmacy directly to the patient.
Pharmacy sourcing is where compounded programs differ most from one another. Because there is no FDA review of the final product, quality rests on the dispensing pharmacy's licensing, state board oversight, and internal testing. "Which pharmacy, and in which state is it licensed?" is a fair question to ask any program, and a legitimate one will answer it.
Dose Forms and Administration
Wegovy is supplied as a single-use, fixed-dose autoinjector pen for once-weekly injection, and more recently as a daily oral tablet. Doses follow the FDA-approved titration schedule printed in the labeling.
Compounded semaglutide is commonly supplied as a multi-dose vial with syringes, and the dose, concentration, and schedule are whatever the prescribing provider specifies for that patient. That flexibility is part of why compounding exists — and it also means you are measuring doses yourself, so clear instructions and provider follow-up matter.
How a Provider Decides
Whether Wegovy or a compounded semaglutide preparation is appropriate for you is a clinical decision. A licensed provider will weigh your BMI and weight-related conditions, medical and family history, current medications, prior response to GLP-1 therapy, and whether a patient-specific formulation serves a clinical purpose for you. Cost is not the basis for that decision, and no reputable program should present it that way.
- Your insurance covers Wegovy. A covered, FDA-approved product with full regulatory oversight is generally the sensible choice.
- You want FDA-reviewed manufacturing and labeling. That is exactly what approval provides, and it is a legitimate reason to choose Wegovy.
- Your provider recommends the approved product based on your history — some patients have clinical reasons to prefer it.
- Your provider determines a compounded preparation is clinically appropriate for you. In that case, a program that names its pharmacy, screens every intake through licensed providers, and holds LegitScript certification is the standard to hold it to.
Side Effects Don't Care Which You Choose
Nausea, vomiting, diarrhea, and constipation are the most common side effects of semaglutide in any form, especially during dose increases. It should not be used by people with a personal or family history of medullary thyroid carcinoma or MEN 2, a history of pancreatitis, or during pregnancy. Both routes require provider screening — our guide to GLP-1 eligibility covers who qualifies and who shouldn't take these medications.
Frequently Asked Questions
Is compounded semaglutide the same as Wegovy?
No. Wegovy is Novo Nordisk's FDA-approved semaglutide product, manufactured and reviewed under FDA oversight. Compounded semaglutide is prepared by a licensed US compounding pharmacy for an individual patient pursuant to a licensed provider's prescription. The compounded final product is not FDA-approved, does not undergo FDA review for safety, effectiveness, or manufacturing quality, and its formulation may differ from the commercial product.
Is compounded semaglutide a generic version of Wegovy?
No. A generic drug is an FDA-approved copy of a brand-name drug that has been reviewed by the FDA for equivalence. Compounded semaglutide has not been through that process. It is not a generic, and it is not a substitute for Wegovy or any other FDA-approved semaglutide product.
Why is compounded semaglutide still available after the FDA shortage ended?
When the FDA declared the semaglutide shortage resolved in 2025, mass compounding of copies wound down, and large platforms like Hims and Ro exited. Licensed compounding pharmacies may still prepare medications for an individual patient when a licensed provider writes a prescription for a clinically appropriate, patient-specific formulation. That is the basis on which smaller telehealth programs continue to operate.
Is Wegovy safer than compounded semaglutide?
Wegovy has FDA-reviewed manufacturing, labeling, and clinical trial data behind it — that oversight is the core advantage of an FDA-approved product. Compounded medications do not undergo FDA review; quality depends on the dispensing pharmacy, which is why it matters that the pharmacy is US-licensed and state-regulated. Both routes require a prescription and provider screening, and both carry the side effects associated with semaglutide.
How does a provider decide between Wegovy and compounded semaglutide?
It is a clinical decision based on your health history, current medications, prior response to treatment, and whether a patient-specific formulation is appropriate for you. It is not a cost decision. If an FDA-approved product is available and appropriate, many providers will prescribe it; compounded medication may be considered when a provider determines that an individualized preparation is clinically appropriate.
This article is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any weight loss medication. FitFlow is a telehealth platform and does not manufacture or compound medications. Compounded medications are prepared and dispensed by licensed U.S. compounding pharmacies pursuant to a prescription from a licensed provider; compounded drugs are not FDA-approved, do not undergo FDA review for safety, effectiveness, or manufacturing quality, and are not a generic version of or substitute for any FDA-approved drug. Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. FitFlowRx is not affiliated with Novo Nordisk, Hims, or Ro.
Talk to a licensed provider
FitFlowRx compounded semaglutide programs include the provider consultation, medication if prescribed, and shipping, with pricing published before checkout. Prescribed only if a licensed provider determines it is appropriate for you. Compounded medications are not FDA-approved.